Home > Insider Trading > Filing (0001209191-20-004146)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
831547	Spectrum Pharmaceuticals Inc	SPPI	Pharmaceutical Preparations (2834)	930979187

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1726378	J Thomas Riga	11500 S. Eastern Ave., Suite 240 Henderson NV 89052	Evp, Coo & Cco	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.001 Par Value	Disposition	2020-01-16	11,381	$3.37	246,678	No	4	S	Direct
Common Stock, $0.001 Par Value	Disposition	2020-01-17	5,000	$3.26	241,678	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, $0.001 Par Value	8,098	Indirect	By 401(k) plan

Footnotes

All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for the purpose of satisfying tax withholding obligations in connection with restricted stock awards granted by the issuer.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.23 to $3.32, inclusive. The reporting person undertakes to provide to Spectrum Pharmaceuticals, Inc., any security holder of Spectrum Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.